Seres Therapeutics Inc（MCRB）の株価予測MCRBSeres Therapeutics Inc

Alphio's MCRB stock price prediction model matches the current Seres Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.96 (-0.35%). The 1-week path is $1.98 (+0.44%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Seres Therapeutics Inc is a good buy right now due to its current price of $1.97, which is significantly lower than its 52-week high of $29.98, indicating substantial upside potential. The forward P/E ratio stands at 10.82, suggesting that the stock is undervalued relative to its future earnings potential. Additionally, the recent positive earnings report showed a net income of $4.6 million for Q2, a turnaround from a loss of $19.9 million in the same quarter last year, which reflects improving financial performance.

Seres Therapeutics Inc (MCRB) last closed at $1.97, losing -5.74%. These facts feed the 1-day and 1-week MCRB price prediction above.